24 December 2017

TIKOMED CEO WILL BE MODERATING THE ”EVOLVING BIOPHARMA BOARDS” AT THE EAST/WEST CEO MEETING PRECEEDING JPMORGAN HEALTH CONFERENCE

Adam Bruce, CEO of TikoMed will be moderating the ”Evolving Biopharma Boards” panel discussion at the East/West CEO meeting preceeding J.P. Morgan Healthcare Conference
Panelists will include the below seasoned Biopharma leaders:
Martin Babler, CEO, Principia Biopharma; William Heiden, President & CEO, AMAG Pharmaceuticals; Catherine Sohn, Chairman, BioEclipse Therapeutics
Moderator: Adam Bruce, CEO, TikoMed
Adam Bruce, says: I am deeply honored to lead the panel for such an important subject. In the pharma world it is of absolute essence to have an aligned chain of competence, starting with owners,followed by the board and finally management. Given the phases of pharma development, it is in my opinion essential,to balance an evolution with continuity. I am excited to hear the panelists thoughts and experiences on the subject.
East/West CEO is a networking forum for industry CEOs and decision makers in the life sciences. Attendees gain insights from presentations and discussion panels featuring CEOs from several of the world’s leading biopharmaceutical companies. Healthcare investors also attend.
The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

DATE
TBA

TIME
TBA

VENUE
TBA

OTHER NEWS

2 November 2018
First patient treated with ILB in TIKOMED’s clinical trial for ALS
Viken, November 2nd, 2018 — TIKOMED, a specialty pharmaceutical company focused on developing therapeutics for…
Read More
20 August 2018
TIKOMED to initiate ALS clinical trial for which the UK Medicines and Healthcare products Regulatory Agency has granted permission
Viken, August 20th, 2018 — TIKOMED, a specialty pharmaceutical company focused on developing therapeutics for…
Read More
14 August 2018
TIKOMED Announce Start of ALS Study at Sahlgrenska University Hospital
VIKEN, Sweden, August 14, 2018 – ​TIKOMED, a specialty pharmaceutical company focused on developing therapeutics…
Read More
SEE MORE